WITHIN THE LAST 'EW YEARS there have been several reports on successful induction of in vitro neoplastic transformation of epithelial cells of skin (Colburn et al., 1978) , salivary gland (Knowles & Franks, 1977) , bladder (Hashimoto & Kitagawa, 1975) , liver (Borenfreund et al., 1975) and trachea (Steele et al., 1977 (Steele et al., , 1979 . We are interested in following the course of antigen expression during early stages of neoplastic development. The rat tracheal explant system appears to be well suited for such studies. Carcinogen exposure of primary tracheal explants in vitro leads to the appearance of transformed cell lines (Steele et al., 1977 (Steele et al., , 1979 . Earlypassage cells are often not tumorigenic, but late-passage cell lines are. In order to determine whether a change in antigen expression during neoplastic development 17 occurs, it was necessary to show that tumorigenic tracheal epithelial cells transformed in vitro express antigens not present on untransformed cells, and to find the means to quantitate such antigens. While it has been established that tracheal tumours induced by carcinogenic polycyclic aromatic hydrocarbons in vivo express antigens capable of stimulating host responses (Jamasbi & Nettesheim, 1977a; Jamasbi et al., 1978) there have been no reports on the immunogenicity of tracheal epithelial cell lines transformed in vitro. We report here that tumorigenic cell lines derived from rat tracheal explants exposed to N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) are immunogenic in adult syngeneic rats. While both cellular and humoral responses can be detected, the antibody response will be most useful G. R. BRASLAWSKY, V. STEELE, S. J. KENNEL AND P. NETTESHEIM for studying the emergence of malignant cell populations. Such studies are reported below.
MATERIALS AND METHODS
Cell lines.-The two tracheal cell lines used originated from tracheal explants which were exposed for 6 h on Days 3 and 6 of culture to 10 jtug MNNG/ml in Waymouth's MB 752/1 medium (Marchok et al., 1975 (Marchok et al., , 1977 . Explants were obtained from 10-12-week-old female Fischer-344 rats. After each carcinogen exposure, cells were incubated in complete medium (Waymouth's medium supplemented with 10% FCS, insulin, hydrocortisone, nonessential amino acids and fatty acids; see Marchok et al., 1977) . Primary cultures were established from explants and stable epithelial cell lines were obtained as described previously (Steele et al., 1977) . Cell lines were passaged weekly by trypsin dissociation as described by Steele et al. (1979) .
Cell lines at various passage levels were tested for tumorigenicity in either immunosuppressed syngeneic rats or athymic BALB/c (nu/nu) mice. Rats were immunosuppressed (thymectomized and whole-body X-irradiated) as described by Jamasbi &Nettesheim (1977b) , and were inoculated i.m. with 106 viable cells in 0-2 ml Hanks's balanced salt solution (HBSS). Athymic BALB/c (nu/nu) mice were inoculated s.c. with 106 cells in 0-1 ml HBSS. Animals were checked weekly for tumour development.
The two cell lines, 8-10-2 and 2-10-1, were used to immunize syngeneic rats and as cell targets to demonstrate host immune responses. For these purposes, cultures were propagated in complete Waymouth's media in which syngeneic F-344 rat serum (supplemented to 2%) was substituted for FCS for at least 2 passages before use.
Induction of transplantation immunity.-F-344 female rats (10-12 weeks old) were inoculated with tumorigenic passages of either 8-10-2 or 2-10-1 cells. Tumour-bearing legs were amputated when tumours were 3-5 cm in diameter (45-60 days for 2-10-1 and 30-50 days for 8-10-2). These animals were rechallenged (s.c.) 14-21 days later and subsequent tumour growth was surgically removed. This procedure continued until the animals rejected the challenge dose.
Microcytotoxicity assay.-The 20h microcytotoxicity assay (Takasugi & Klein, 1970) Spleen cells from immune rats were also co-cultivated in vitro with epithelial cell populations which had been lethally irradiated. Cells were X-irradiated as monolayer cultures in HBSS with 10 krad (250 rad/min). Irradiated cells were removed by trypsinization and showed viability of > 90%. Normal lymphocytes were similarly irradiated but as a single-cell suspension.
Both irradiated (2 x 105/ml) and responding (2 x 106/ml) cell populations were suspended in RPMI 1640 medium containing 10% FCS, L-glutamine, antibiotics and 5 x 10-5M 2-248 mercaptoethanol (Cerottini et al., 1974) . One ml of each cell population was incubated in 12 x 75mm plastic tubes (Falcon No. 2054) for 6 days in a humidified 37°C incubator. To compensate for shifts in pH during incubation, the medium was buffered with 3-7 g/l sodium bicarbonate and incubated in 800 C02-air.
After co-cultivation, cells from each group were pooled, washed x 3 and the viability was determined. Responder spleen cells were used as effector cells in 20h microcytotoxicity assays as described above. Controls consisted of spleen cells incubated for 6 days with irradiated lymphocytes from normal F-344 rats.
Antibody binding test (ABT).-Target cells
were grown as monolayer cultures on 10-5 x 22mm glass coverslips (Bellco Glass Co.).
Directly before use, monolayer coverslips were chilled in cold HBSS, drained and floated cell-side down for 1 h at 4°C on 0-1 ml antiserum diluted in HBSS. Coverslips were washed in 2 changes of chilled HBSS to remove unbound antibody, and floated on 0-1 ml radiolabelled affinity-chromatographypurified, rabbit antibody to rat IgG (PARG) (Kennel & Feldman, 1976) for 1 h at 4°C (0.5 ,ug antibody protein per reaction). PARG was radiolabelled to specific activities of 5-10 x 105 ct/min/,ug with Na125I (New England Nuclear) using Chloramine T (McConahey & Dixon, 1966) . Coverrlips were washed in 3 changes of cold HBSS to remove unbound label, and cell-bound radtioactivity was determined with a Searle Model 1185 y-counter.
Controls consisted of monolayer cultures incubated with: (a) HBSS followed by labelled PARG and (b) cell monolayers incubated with diluted normal rat serum (NRS). In all cases, nonspecific binding (NRS control) was subtracted from experimental values before estimating the amount of labelled antibody protein specifically bound to target-cell monolayers.
Fluorescent antibody tests.-Coverslips of 8-10-2 or 2-10-1 cells or normal cells from primary tracheal outgrowths were prepared as described above. The cells were washed and incubated with normal or immune serum as described above for the ABT, except that fluorescein isothiocyanate-conjugated PARG was substituted for radioiodinated PARG. Cells were viewed on a Zeiss model microscope with epi-illumination.
RESULTS

Development of tumorigenicity of tracheal cell lines
As described previously (Steele et arl., 1979) exposure of primary tracheal explhnt cultures to MNNG in vitro produced stable epithelial cell lines. Tumorigenicity of the MNNG-induced tracheal cell lines was determined by inoculation at various passages of 106 cells into immunosuppressed F-334 rats or BALB/c (nu/nu) mice (Table I) culture can adsorb antigenic determinants from the serum in culture medium (Embleton & Iype, 1978) In order to test more fully for the presence of antigen-bearing cells among normal or transformed epithelial cells (Engers & MacDonald, 1976) immune spleen cells were co-cultivated for 6 days in vitro with primary tracheal-outgrowth cultures or neoplastic epithelial cell lines before 20h microcytotoxicity testing. As shown in Table IV , significant reactivity for the immunizing target cell was obtained when immune spleen cells were co-cultivated with either of the neoplastic cell lines. No cytotoxicity of immune spleen cells for neoplastic target cells was detected after co-cultivation with normal tracheal outgrowths. Residual cytotoxicity of immune spleen cells was also lost during 6-day co-cultivation with irradiated lymphocytes, indicating that antigen-bearing cells must be present to maintain the cytotoxic lymphocytes. No significant differences were detected between targetcell numbers in buffer control and normallymphocyte control, with one exception, where an increase in number of target cells (expressed as a negative response) was observed (Table IV) .
Detection of circulating antibody Sera obtained from immune rats were first tested for antibody activity against 8-10-2 and 2-10-1 cell lines by the ABT. The specificity of antibody binding was determined by absorption of immune sera. Antibody binding of anti-2-10-1 serum (diluted 1: 80) was compared to binding after absorption with either normal lung homogenates or tumour homogenates from 2-10-1 cells propagated in vivo (Fig.  4A) . Absorption with normal-lung homogenates did not significantly reduce anti-2-10-1 activity for 2-10-1 monolayers. In contrast, absorption of 2-10-1-immune serum with 2-10-1 cell homogenates removed 94% of the binding activity. Analogous results were obtained with 8-10-2-immune serum (Fig. 4B) . The ability of homologous tumour-cell absorptions to remove antibody activity of immune sera provided strong evidence that binding activity of such antisera were not directed against foetal calf serum or other in vitro components.
Cross-reactivity between the two malignant cell lines was demonstrated by serial absorptions of serum obtained from transplantation-resistant rats. Fig. 5A shows the residual binding activity of anti-2-10-1 serum on 2-10-1 cell monolayers after absorption with normal tissue or tumour-cell homogenates. Absorption with normal-tissue homogenates removed less than 15% of the original antibody activity, whereas 82% of the original antibody activity was removed by 3 absorptions with 8-10-2 tumour homogenates. Two absorptions using homologous 2-10-1 tumour homogenates removed >98% of Both anti-8-10-2 and a positive on homologou layers. In addition, 8 serum stained the sur both neoplastic cell lii 50% of the neoplastic cells were stained, whereas nonspecific fluorescence, as determined using NRS as controls, never exceeded 5% of the cells. Under these conditions, neither 8-10-2-nor 2-10-1-immune rat sera demonstrated staining on primary tracheal outgrowths. Endogenous C-type virus activity Cell lines used in these studies were analysed for C-type viral gene products. First, lysates of cells grown to confluency were analysed for the major core protein p30 using an interspecific radioimmunoassay (Strand & August, 1974; Kennel & Tennant, 1979) . This type of assay has been shown to detect p3Os from rat, mouse, and cat viruses (Strand & August, 1974; Rasheed et al., 1976) . Cell lysates from confluent 100mm plates of 8-10-2 or 2-10-1 cells (t 5 x 106 cells) contained less than 5 ng of p30, which was 50-100 times less than in virus-infected fibroblast cultures. Secondly, putative virus pellets, concentrated 100-fold from culture fluids, were analysed for reverse-transcriptase activity by the method of Ross et al. (1971) . (Kennel, 1976 vas assessed subjectively was no detectable expression of C-type rrescing) or + (>5% of wsn eetbeepeso fCtp viral genes in the rat tracheal-cell lines, which are unlikely to be factors in the ,nti-2-10-1 sera were immune response of syngeneic animals. is target-cell mono--10-2-immune antiface membranes of nes (Table V) lines derived from rat tracheal explants transformed in vitro by MNNG acquire antigens capable of stimulating syngeneic immunological responses. The two transformed epithelial cell lines used in this report were shown to be immunogenic by induction of transplantation resistance against tumorigenic inocula. Once transplantation immunity was established, both humoral and cell-mediated immune responses were evident. Previous studies using in vivo carcinogen-induced pulmonary adenomas of mice (Prehn, 1962; Pasternak et al., 1966) and tracheal and pulmonary squamous carcinomas of rats (Jamasbi et al., 1978) have suggested that respiratory-tract tumours are either poorly immunogenic or incapable of eliciting any type of syngeneic immune response. Immunogenicity of both in vitro carcinogeninduced cell lines was weak, but demonstrable, and is consistent with findings from in vivo chemical induction.
Cell-mediated immune responses were demonstrated with both primary effector spleen cells (freshly harvested) or after in vitro co-cultivation with eitherneoplastic cell line before microcytotoxicity assay (secondary effector cells). Reactivity of primary spleen effector cells was limited to the neoplastic cell lines, and spleen-cell reactivity against untransformed tracheal outgrowths was not detected. Furthermore, reactivity of secondary effector spleen cells for neoplastic cell targets was maintained only by co-cultivation in vitro with the neoplastic cell lines. Normal tracheal outgrowths were incapable of generating secondary effector cells in vitro. These results support the conclusion that immune spleen cells were reacting with tumour-cell antigens not present in the normal cell population
We have also demonstrated that sera from immune rats contained antibody directed at cell-surface antigens on neoplastic epithelial cell lines. Anti-tumour antibody to rat respiratory-tract carcinomas induced in vivo (Jamasbi & Nettesheim, 1977a; Jamasbi et al., 1978) and to human respiratory-tract carcinomas (Gorny et al., 1979; Sofen & O'Toole, 1978) has been reported. In all cases, some activity was also detected against normal respiratory tissue. We were not able to detect significant antibody activity against normal respiratory-tract tissues by antiserum absorptions with lung homogenates. Indirect immunofluorescence, which supported the findings of the ABT, also failed to reveal any evidence of antibody activity for normal primary outgrowths.
The cross-reactivities of 8-10-2 and 2-10-1 cell lines have not been evaluated in vivo. However, common tumour-rejection antigens were found among several benzo(a)pyrene or dimethylbenz(a)-anthracene respiratory-tract carcinomas induced in vivo in F-344 rats (Jamasbi & Nettesheim, 1 977b) . The cross-reactivity obtained in vitro using spleen cells from tumour-immune animals appears to be specific for the transformed cell lines, since no reactivity was found for untransformed tracheal epithelial cells. Furthermore, it is unlikely that cross-reactivity between the two epithelial cell lines was due to an endogenous viral genome activated during in vitro carcinogenesis (Rasheed, 1979) . No evidence of reverse-transcriptase activity was found in these cell lines, and binding of tumour-immune or tumour-bearing sera to the gp7O macromolecule of murine leukaemia virus was not demonstrable.
The presence of common antigens on the surface of 8-10-2 and 2-10-1 cell lines was also demonstrated by absorption experiments. Absorption of 2-10-1 -immune serum with 8-10-2 homogenates decreased antibody binding to plateau levels of about 80% of the original activity. Quantitative absorption tests with enhanced sensitivity will have to be used to determine whether specificities for a single tumour type are also present in tumour-immune serum.
Rat tracheal-cell explants can be transformed in vitro by carcinogens to generate epithelial cell lines (Steele et al., 1977 (Steele et al., , 1979 which upon continued in vitro propagation become tumorigenic. In this report, we have used the syngeneic immune response to identify cell-surface 255 antigens on the tumorigenic cell populations. Such antigens detected on transformed cell lines must have been acquired as a result of neoplastic transformation, since it was shown that untransformed cell outgrowths lack detectable amounts of these neo-antigens. It is at present not known whether the appearance of neoantigens on chemically altered cells is an essential feature of oncogenesis, or whether it is merely a byproduct of the interaction between the carcinogen and the cells.
